Surgical options for refractory ventricular tachycardia
Sekar Sangameswaran Bhavani1, Patrick Tchou, Walid Saliba
1Department of Thoracic and Cardiovascular Surgery, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.
Journal of Cardiac Surgery
|November 28, 2007
Summary
Surgical ablation offers a curative solution for ventricular tachycardia (VT) when drug therapy and percutaneous ablation fail. Tailoring surgical approaches ensures effective treatment for diverse VT origins.
Area of Science:
- Cardiology
- Cardiac Surgery
- Electrophysiology
Background:
- Ventricular tachycardia (VT) is a serious arrhythmia often managed with antiarrhythmic drugs.
- Percutaneous endocardial ablation guided by electroanatomic mapping is a standard curative treatment for refractory VT.
- Surgical ablation becomes necessary when less invasive methods are unsuccessful or not feasible.
Observation:
- Surgical ablation for VT utilizes advanced electroanatomic mapping and diverse ablation technologies.
- Treatment strategies must be individualized, considering patient anatomy and clinical presentation.
- Surgical approaches include endocardial or epicardial, and beating-heart or arrested-heart techniques.
Findings:
- The presented cases demonstrate the versatility of surgical ablation for VT originating from various cardiac locations.
- Successful surgical ablation requires careful selection of approach and device based on individual patient factors.
- This approach provides a crucial alternative for complex or treatment-resistant VT cases.
Implications:
- Surgical ablation represents a vital therapeutic option for patients with intractable ventricular tachycardia.
- Personalized surgical strategies can improve outcomes in complex arrhythmia management.
- Further research into tailored surgical techniques may enhance the efficacy of VT ablation.
Related Concept Videos
Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiopulmonary Resuscitation IV: Pharmacological Management
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...


